Dr. Emily von Scheven of the University of California at San Francisco discusses the development of consensus treatment plans for proliferative nephritis in juvenile systemic lupus.
Dr. Deborah McCurdy and Dr. Ornella Rullo found that high levels of a protein called osteopontin may be a predictor of future lupus disease activity and organ damage.
Dr. Michelle Petri of the Johns Hopkins University Medical Center discussed the results of a study of vitamin D supplementation in people with lupus.
Dr. Eyal Muscal of the Baylor School of Medicine reports on the results of a study that used advanced brain imaging to evaluate changes in the brains of adolescents with lupus.
Dr. Anne Stevens of the University of Washington, Seattle Children’s Hospital discusses her study to evaluate the role of the protein PD-L1 to help doctors determine whether an illness is lupus-related or the result of an infection.
Dr. Kenneth Kalunian discusses the results of a study to examine the effect of background medications taken by individuals enrolled in lupus clinical trials.
Dr. Meenakshi Jolly, of Rush University Medical Center in Chicago, discusses the results of a study to validate an instrument to measure disease activity and quality of life.
Dr. S. Sam Lim of Emery University School of Medicine discusses the Georgia Lupus Registry which found black women have a significantly higher incidence of lupus than most reports in the scientific literature.